Polikoff, Adam
Wessner, Corinne E.
Balasubramanya, Rashmi
Dulka, Susan
Liu, Ji-Bin
Machado, Priscilla
Savsani, Esika
Lyshchik, Andrej
Shaw, Colette M.
Eisenbrey, John R. http://orcid.org/0000-0001-6411-3424
Funding for this research was provided by:
Foundation for the National Institutes of Health (CA194307, CA215520)
Article History
Received: 9 August 2021
Revised: 24 September 2021
Accepted: 27 September 2021
First Online: 13 October 2021
Declarations
:
: CEW declares that he is a consultant in Bracco Imaging. AL declares that he is a research supporter in GE Healthcare, Bracco Diagnostics, Siemens Healthineers, and Canon Medical Systems, is a member of advisory board in Bracco Diagnostics, is a consultant in GE Healthcare, Bioclinica, and WorldCare Clinical, and is one of the members of speaker panel in GE Healthcare, and has book royalties in Elsevier. JRE received grant and equipment support from GE Healthcare, equipment support from Siemens, and drug support and speaker honorarium from Lantheus Medical Imaging. All other authors have no conflict of interest to declare.
: This study was approved by the university’s Institutional Review Board.
: All patients in this trial provided informed consent to participate in the initial contrast-enhanced ultrasound study.
: Consent to publish de-identified images and data were included in the informed consent process.